Location: Home
  • search
  • go
  • Relate News
  • 3/6/2012EntreMed to open a China office as it terminates SVT licensing deal
  • 3/2/2012Three PE firms took over majority stake of Singapore-listed Luye Pharm...
  • 2/29/2012IFPMA expands its Code of Practice to update ethical standards
  • 2/28/2012Cumberland, Harbin Gloria enter agreement for distribution of Acetadot...
  • 2/28/2012Chinese CRO Newsummit Biopharma files $80M IPO in the U.S.
  • 2/28/2012Tibet Pharma to accept CEO buyout and delist
  • 2/28/2012Keyuan Xinhai enters strategic alliance with Guangdong CDC
  • 2/28/2012China will raise subsidy and reimbursement levels of NRCMS further thi...
  • 2/28/2012Recent executive and official moves
  • 2/27/2012The SFDA Complaint and Reporting Center becomes operational
  • 2/24/2012Access Pharmaceuticals Receives Final Marketing Approval From SFDA of ...
  • 2/22/2012State Council meeting outlines healthcare reform direction before 2015
  • 2/21/2012China Health Resources signs LOI for acquisition of NJ-based Herborium...
  • 2/21/2012Chinese pharmaceutical industry revenues up 30% in 2011
  • 2/20/2012BGI enters new collaboration with Asia Cancer Research Group
  • 2/20/2012Vice Health Minister Yin Li appointed the new SFDA Commissioner
  • 2/20/2012BMS Foundation awards three grants for HBV and HCV in China and India
  • 2/17/2012Asymchem expands Chinese CMO capacity with a new facility in Jilin pro...
  • 2/17/2012Health Minister Chen Zhu comments on NEDL expansion and other reform i...
  • 2/16/2012Shanghai Pharma sets up base in North China with US$80M
  • 2/15/2012Gansu Duyiwei acquires Qili Pharma and plans mAb licensing from Apexig...
  • 2/15/2012Unis Guhan Group put up its stake in Nanyue Pharma for sale
  • 2/14/2012GSK creates a new DPU in China to tap new drug leads from TCMs
  • 2/14/2012A traditional Chinese medicine found to fight ageing
  • 2/14/2012Some local governments initiate zero drug sales margin experiment in p...
  • 2/14/2012MOH begins appraisal of public hospital reform experiment
  • 2/14/2012Latest executive moves
  • 2/13/2012Sichuan Xieli Pharma gains EU-GMP
  • 2/10/2012Marken steps up presence in China
  • 2/9/2012BioDiem licenses its LAIV vaccine technology to Changchun BCHT Bio
  • Page:292/367 Total number of articles:10996: [First][<<] [290] [291] [292] [293] [294] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group